Menu
Search
|

Menu

Close
X

TherapeuticsMD Inc TXMD.OQ (NASDAQ Stock Exchange Global Select Market)

2.15 USD
-0.07 (-3.15%)
As of Jul 23
Previous Close 2.22
Open 2.23
Volume 741,830
3m Avg Volume 863,912
Today’s High 2.25
Today’s Low 2.14
52 Week High 6.93
52 Week Low 2.14
Shares Outstanding (mil) 241.22
Market Capitalization (mil) 535.51
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.86 Mean rating from 7 analysts

KEY STATS

Revenue (mm, USD)
FY19
4
FY18
16
FY17
17
FY16
19
EPS (USD)
FY19
-0.164
FY18
-0.587
FY17
-0.375
FY16
-0.458
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
34.39
Price to Sales (TTM)
vs sector
32.91
8.16
Price to Book (MRQ)
vs sector
8.82
4.43
Price to Cash Flow (TTM)
vs sector
--
24.27
Total Debt to Equity (MRQ)
vs sector
121.10
17.60
LT Debt to Equity (MRQ)
vs sector
121.10
12.56
Return on Investment (TTM)
vs sector
-120.97
12.67
Return on Equity (TTM)
vs sector
-175.86
17.18

EXECUTIVE LEADERSHIP

Tommy Thompson
Independent Chairman of the Board, Since 2012
Salary: --
Bonus: --
John Milligan
President, Secretary and Director, Since 2011
Salary: $450,000.00
Bonus: $78,750.00
Robert Finizio
Chief Executive Officer and Director, Since 2012
Salary: $600,000.00
Bonus: $150,000.00
Brian Bernick
Co-Founder and Director, Since 2018
Salary: --
Bonus: --
Daniel Cartwright
Chief Financial Officer and Treasurer, Since 2015
Salary: $375,000.00
Bonus: $65,625.00

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

6800 Broken Sound Pkwy NW
BOCA RATON   FL   33487-2721

Phone: +1561.9611911

TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone therapy pharmaceutical products. Its drug candidates used in clinical trials are designed to alleviate symptoms of and reduce health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis and vaginal discomfort. With its SYMBODA technology, it is developing hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through dosage forms and administration routes. Its product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew.

SPONSORED STORIES